We found data on prevalence of LDA prescribing and anemia (or Hb levels) in three studies in community settings [40-42], noted as patient characteristics in three studies of treatment of cardiovascular disease in older patients [43-45], and in four studies in secondary care in patients considered for investigation of anemia [46-49]. This evidence concerns the gene GSTM1 and cardiovascular disorder.